scholarly journals Usefulness of the Comprehensive Geriatric Assessment in Older Patients with Upper Gastrointestinal Bleeding: A Two-Year Follow-Up Study

2007 ◽  
Vol 25 (2) ◽  
pp. 124-128 ◽  
Author(s):  
Alberto Pilotto ◽  
Luigi Ferrucci ◽  
Carlo Scarcelli ◽  
Valeria Niro ◽  
Francesco Di Mario ◽  
...  
Keyword(s):  
Gastrointestinal Bleeding ◽  
Geriatric Assessment ◽  
Comprehensive Geriatric Assessment ◽  
Older Patients ◽  
Upper Gastrointestinal Bleeding ◽  
Follow Up Study ◽  
Upper Gastrointestinal

scholarly journals Isolated Splenic Vein Thrombosis: 8-Year-Old Boy with Massive Upper Gastrointestinal Bleeding and Hypersplenism

2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
Mohammad Ali Kiani ◽  
Arash Forouzan ◽  
Kambiz Masoumi ◽  
Behnaz Mazdaee ◽  
Mohammad Bahadoram ◽  
...  
Keyword(s):  
Gastrointestinal Bleeding ◽  
Esophageal Varices ◽  
Upper Gastrointestinal Bleeding ◽  
Splenic Vein ◽  
Recurrent Bleeding ◽  
Vein Thrombosis ◽  
One Year ◽  
The One ◽  
Upper Gastrointestinal

We present an 8-year-old boy who was referred to our center with the complaint of upper gastrointestinal bleeding and was diagnosed with hypersplenism and progressive esophageal varices. Performing a computerized tomography (CT) scan, we discovered a suspicious finding in the venography phase in favor of thrombosis in the splenic vein. Once complementary examinations were done and due to recurrent bleeding and band ligation failure, the patient underwent splenectomy. And during the one-year follow-up obvious improvement of the esophageal varices was observed in endoscopy.

scholarly journals Bochdalek Hernia in an Adult with Upper Gastrointestinal Bleeding

2017 ◽  
Vol 11 (2) ◽  
pp. 284-292 ◽  
Author(s):  
Mohammed Al-Dugdugi ◽  
Abdulhameed Alhazmi ◽  
Abdulhadi Khaliel ◽  
Luis Perez
Keyword(s):  
Acute Pancreatitis ◽  
Gastrointestinal Bleeding ◽  
Upper Gastrointestinal Bleeding ◽  
Bochdalek Hernia ◽  
Threatening Condition ◽  
Lethal Complications ◽  
Life Threatening ◽  
Hernial Repair ◽  
Upper Gastrointestinal

Bochdalek hernia (BH) can be a life-threatening condition in infants. Approximately 85.3% of newborns with a BH are immediately at high risk and have a high mortality rate due to respiratory insufficiency [Kocakusak et al.: Hernia 2005;9: 284–287]. However, BH is almost asymptomatic in adults and discovered only incidentally [Wilkins et al.: Clin Imaging 1994;18: 224–229]. Complicated BH in adults might present with visceral incarceration and lethal complications. Upper gastrointestinal bleeding and acute pancreatitis are rarely reported in the literature as complications of BH in adults. Here we report the case of a 42-year-old male who presented with upper gastrointestinal bleeding and acute pancreatitis. He was found to have abdominal visceral organ herniation to the posterior right thoracic cavity. His diagnosis was achieved early and with a close follow-up, we succeeded in stabilizing the patient’s condition. Then he was subjected to reconstructive thoracotomy for hernial repair and restoring abdominal viscera.

Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation

2013 ◽  
Vol 110 (12) ◽  
pp. 1298-1304 ◽  
Author(s):  
Lucía Soriano ◽  
Héctor Bueno ◽  
Angel Lanas ◽  
Luis Rodríguez
Keyword(s):  
Gastrointestinal Bleeding ◽  
Acetylsalicylic Acid ◽  
Low Dose ◽  
Upper Gastrointestinal Bleeding ◽  
Cardiovascular Prevention ◽  
Health Improvement ◽  
Coronary Death ◽  
Upper Gastrointestinal ◽  
Secondary Cardiovascular Prevention

SummaryIt was the aim of this study to investigate whether low-dose acetylsalicylic acid (ASA) therapy for secondary cardiovascular prevention should continue, despite the risk of gastrointestinal bleeding. We aimed to make a clinically meaningful benefit–risk assessment regarding the cardiovascular and gastrointestinal consequences of ASA discontinuation. This case–control study used The Health Improvement Network UK primary care database to identify patients aged 50–84 years during 2000–2007 with a first ASA prescription for secondary cardiovascular prevention (N = 39,513). New cases of non-fatal myocardial infarction (MI)/coronary death (n = 1,222), ischaemic stroke (IS)/transient ischaemic attack (TIA) (n = 673) and upper gastrointestinal bleeding (UGIB) (n = 169) were identified after a mean follow-up of 3.2, 3.4 and 4.0 years, respectively. ASA discontinuers before the index date were identified. Attributable risks associated with ASA discontinuation were calculated and National Institute for Health and Clinical Excellence annual economic data were used to estimate healthcare costs. The cumulative incidences of non-fatal MI/coronary death, IS/TIA and UGIB among ASA discontinuers within the first year of follow-up were 17, 11 and 1.6 per 1,000 persons, respectively. This corresponds to eight extra cardiovascular events, and a reduction of 0.4 UGIB events per year compared with current ASA users. Extrapolating to the UK population aged over 50 years, avoiding discontinuation of ASA could prevent 12,786 coronary and 7,672 cerebrovascular events/year, at the expense of 1023 extra UGIB events, saving approximately £100 million/year. In conclusion, preventing patients with cardiovascular disease from discontinuing ASA could result in substantial clinical and economic gains.

Sign in / Sign up

Export Citation Format

Share Document